These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 598785)

  • 1. [Studies of sulfhemoglobin formation by various drugs (3) (author's transl)].
    Nomura A
    Nihon Yakurigaku Zasshi; 1977 Oct; 73(7):793-802. PubMed ID: 598785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Studies on sulfhemoglobin formation by various drugs (2) (author's transl)].
    Nomura A
    Nihon Yakurigaku Zasshi; 1977 May; 73(4):423-35. PubMed ID: 908543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Formation of sulfhemoglobin using various drugs].
    Nomura A
    Nihon Yakurigaku Zasshi; 1975 May; 71(4):351-65. PubMed ID: 1237450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies of sulfhemoglobin formation by various drugs (4). Influences of various antidotes on chemically induced methemoglobinemia and sulfhemoglobinemia (author's transl)].
    Nomura A
    Nihon Yakurigaku Zasshi; 1980 Sep; 76(6):435-46. PubMed ID: 7203279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of exposure to N-phenyl-alpha-naphthylamine, octyl-phenyl-alpha-naphthylamine, and dioctyldiphenylamine on the development of frog embryos.
    Greenhouse G
    Bull Environ Contam Toxicol; 1976 Nov; 16(5):626-9. PubMed ID: 1086692
    [No Abstract]   [Full Text] [Related]  

  • 6. Interpreting sulfhemoglobin and methemoglobin in patients with cyanosis: An overview of patients with M-hemoglobin variants.
    Rangan A; Savedra ME; Dergam-Larson C; Swanson KC; Szuberski J; Go RS; Porter TR; Brunker SE; Shi M; Nguyen PL; Hoyer JD; Oliveira JL
    Int J Lab Hematol; 2021 Aug; 43(4):837-844. PubMed ID: 34092029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-wavelength method for the optical differentiation of methemoglobin and sulfhemoglobin in oxygenated blood.
    Van Leeuwen SR; Baranoski GVG; Kimmel BW
    Annu Int Conf IEEE Eng Med Biol Soc; 2017 Jul; 2017():4570-4573. PubMed ID: 29060914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical properties of anti-inflammatory drugs. XI. Structure-action relationship for the uncoupling of oxidative phosphorylation and inhibition of chymotrypsin by N-substituted anthranilates and related compounds.
    Whitehouse MW
    Biochem Pharmacol; 1967 May; 16(5):753-60. PubMed ID: 6036726
    [No Abstract]   [Full Text] [Related]  

  • 9. Sulfhemoglobinemia after dermal application of DMSO.
    Burgess JL; Hamner AP; Robertson WO
    Vet Hum Toxicol; 1998 Apr; 40(2):87-9. PubMed ID: 9554060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of an antalgic-induced (Phenacetin + Acetanilid) sulf and methemoglobinemia in a woman receiving an antimetabolite (Methotrexate) (author's transl)].
    Muller A; Laugner B; Reiss F
    Anesth Analg (Paris); 1981; 38(9-10):551-3. PubMed ID: 7332102
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of the complex treatment on met- and sulfhemoglobin production in patients with varicose and post-thrombophlebitic ulcers of the lower extremities].
    Iupatov SI; Gavrilik BL; Zen'kov LN; Skriabina GA
    Khirurgiia (Mosk); 1986 May; (5):90-2. PubMed ID: 3723962
    [No Abstract]   [Full Text] [Related]  

  • 12. [Anti-inflammatory action of N-(2,6-dichlorophenyl)-o-aminophenylacetic acid, its sodium salt, N-(2,6-dichlorophenyl)-anthranilic acid and its sodium salt. 1. On acute inflammation].
    Tsurumi K; Hiramatsu Y; Nozaki M; Hayashi M; Shibuya T
    Nihon Yakurigaku Zasshi; 1973 Mar; 69(2):299-318. PubMed ID: 4807882
    [No Abstract]   [Full Text] [Related]  

  • 13. Pitfalls in discriminating sulfhemoglobin from methemoglobin.
    Demedts P; Wauters A; Watelle M; Neels H
    Clin Chem; 1997 Jun; 43(6 Pt 1):1098-9. PubMed ID: 9191578
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of some anti-inflammatory, antipyretic and analgesic agents on urinary enzyme level in rats.
    Tsurumi K; Abe A; Nozaki M; Fujimura H
    J Toxicol Sci; 1978 Feb; 3(1):1-9. PubMed ID: 34731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physicochemical properties and uncoupling activity of 3'-substituted analogues of N-phenylanthranilic acid.
    Terada H; Muraoka S
    Mol Pharmacol; 1972 Jan; 8(1):95-103. PubMed ID: 5061521
    [No Abstract]   [Full Text] [Related]  

  • 16. [Changes in the polysaccharide biosynthesis of Candida guilliermondii induced by diphenylamine].
    Phai LD; Reuter G
    Z Allg Mikrobiol; 1976; 16(3):197-9. PubMed ID: 969574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Excretion of organic compounds bei microorganisms in presence of diphenylamine].
    Phai LD; Reuter G
    Z Allg Mikrobiol; 1976; 19(5):369-75. PubMed ID: 823713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Potenial analgesics, IX: synthesis and pharmacological test of derivatives of n-(piperidine-4-yl)anthranilic acid (author's transl)].
    Burkartsmaier A; Mutschler E
    Arch Pharm (Weinheim); 1978 Oct; 311(10):843-8. PubMed ID: 736756
    [No Abstract]   [Full Text] [Related]  

  • 19. Thyroid hormone uptake by hepatocytes: structure-activity relationships of phenylanthranilic acids with inhibitory activity.
    Chalmers DK; Scholz GH; Topliss DJ; Kolliniatis E; Munro SL; Craik DJ; Iskander MN; Stockigt JR
    J Med Chem; 1993 Apr; 36(9):1272-7. PubMed ID: 8487264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral antipyretic therapy: evaluation of the N-aryl-anthranilic acid derivatives mefenamic acid, tolfenamic acid and flufenamic acid.
    Keinänen S; Similä S; Kouvalainen K
    Eur J Clin Pharmacol; 1978 Jul; 13(5):331-44. PubMed ID: 668793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.